Craig Beasley — Chief Technology Officer at BlueRock Therapeutics | Comparably
BlueRock Therapeutics Claimed Company
BlueRock Therapeutics LP is a clinical stage cell therapy harnessing the power of cell therapy to create a pipeline of new medicines for people suffering from neurological and ophthalmic diseases. Two of our novel investigational cell therapies, bemdaneprocel (BRT-DA01) for the treatment of Parkinson’s disease and OpCT-001 for the treatment of primary photoreceptor diseases are clinical stage programs. BlueRock was founded in 2016 as a joint venture of Versant Ventures and Leaps by Bayer. Our culture is defined by the courage to persist regardless of the challenge, the urgency to transform medicine and deliver hope, integrity guided by mission, and community-mindedness with the understanding that we are all part of something bigger than ourselves. read more
This company is accepting feedback from verified employees
EMPLOYEE
PARTICIPANTS
180
TOTAL
RATINGS
5197
Craig Beasley — Chief Technology Officer at BlueRock Therapeutics

Craig Beasley — Chief Technology Officer at BlueRock Therapeutics

Executive Bio

Craig Beasley is the Chief Technical Officer at BlueRock Therapeutics. Prior to joining BlueRock, Craig was the Vice President, Cell Therapy Supply Chain at BMS, where he oversaw supply chain for BMS’s clinical and commercial stage cell therapy assets. Previously, Craig was Head of Manufacturing and Supply Chain at Juno Therapeutics and Vice President of Next Generation Manufacturing at Biogen. Prior to working in biotechnology, Craig worked for Union Carbide in process development. Craig holds a B.S. in Chemical Engineering from Purdue University

Executive Team Culture Ratings from BlueRock Therapeutics Employees

TOP
5%
BlueRock Therapeutics' Executive Team scores in the Top 5%
of similar sized companies on Comparably
Who ranks the Executive Team the highest?
Ethnicity - African American/Black 100/100
Department - HR 98/100
Department - Finance 98/100
Who ranks the Executive Team the lowest?
Ethnicity - Other 81/100
Department - Business Development 88/100
Department - R&D 90/100

BlueRock Therapeutics' Executive Team at a Glance

Based on 357 ratings, BlueRock Therapeutics' employees are very satisfied with their Executive Team and give them an “A+” or 92/100. On average, Women provided higher ratings for their Executive Team compared to Men. Also, the HR department thinks more highly of the Executive Team relative to the Business Development department.

BlueRock Therapeutics' Executive Team ranks in the Top 5% of other companies in Boston and Top 5% of other companies on Comparably that also have 201-500 Employees.

×
Rate your company